Skip to search formSkip to main contentSkip to account menu

6-hydroxywarfarin

Known as: 4,6-dihydroxy-3-(3-oxo-1-phenylbutyl)-2H-1- benzopyran-2-one 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Warfarin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
The impact of the cytochrome CYP2C9*2 and *3 polymorphisms in the South African Caucasian population on warfarin therapy protocols
Pharmacogenetics is a scientific field of study that focuses on biochemical variations in drug response due to genetic factors… 
1997
1997
Conversion of 7-methoxy-3,4-dihydro-2H-1-benzopyran-2-one into the corresponding dimethyl ortho ester
1993
1993
Disposition of drugs in cystic fibrosis. V. In vivo CYP2C9 activity as probed by (S)‐warfarin is not enhanced in cystic fibrosis
Enhanced metabolism of theophylline in subjects with cystic fibrosis suggests that the activity of certain cytochrome P450… 
1993
1993
Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone.
The in vitro human serum albumin binding characteristics of the enantiomers of the major metabolites of warfarin [6… 
1979
1979
Cumene hydroperoxide-supported microsomal hydroxylations of warfarin--a probe of cytochrome P-450 multiplicity and specificity.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)